• No results found

Myeloproliferative Disorders

Original Article Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients

Original Article Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients

... in myeloproliferative disorders is important for proper diagnosis of these ...with myeloproliferative disorders referred to National Cancer institute, Cairo ...negative ...

5

Frequency of L1721W Polymorphism in TET2 Gene Among a Cohort of Sudanese Patients with Myeloproliferative Disorders: Possible Roles in Pathogenicity and Leukemic Transformation

Frequency of L1721W Polymorphism in TET2 Gene Among a Cohort of Sudanese Patients with Myeloproliferative Disorders: Possible Roles in Pathogenicity and Leukemic Transformation

... Abstract: Transformation of myeloproliferative disorders (MPDs) to acute leukemia is an evitable event that represents a stumbling block in the management of patients. The Janus Kinase-2 JAK2V617F mutation ...

5

Evaluation of the JAK2 Gene Mutation in Moroccan Patients with Chronic Myeloproliferative Disorders

Evaluation of the JAK2 Gene Mutation in Moroccan Patients with Chronic Myeloproliferative Disorders

... [14] eugenio lucia1, bruno martino2, corrado mammi3, ernesto vigna1,carla mazzone1, massimo gentile1, gabriele qualtieri1,maria grazia bisconte1, maria naccarato1, carlo gentile1,carmelo lagana` 3, francesco romeo4, ...

8

Characterization of the Platelet Prostaglandin D2 Receptor: LOSS OF PROSTAGLANDIN D2 RECEPTORS IN PLATELETS OF PATIENTS WITH MYELOPROLIFERATIVE DISORDERS

Characterization of the Platelet Prostaglandin D2 Receptor: LOSS OF PROSTAGLANDIN D2 RECEPTORS IN PLATELETS OF PATIENTS WITH MYELOPROLIFERATIVE DISORDERS

... myeloproliferative disorders (polycythemia vera, essential thrombocythemia, and chronic myelogenous leukemia), as over 90% of these patients have platelets resistant to the effects of PGD 2 on aggregation ...

6

Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia

Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia

... erative disorders with ...of myeloproliferative disorders associated with hypereosinophilia is discussed together with open and controversial ...

11

The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-

The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018

... concluded that both spontaneous EEC and histopathology from bone marrow biopsy provide speci ic information as sensitive clues for the diagnosis of all variants of overt and latent myeloproliferative ...

24

Molecular Defects in Chronic Myeloproliferative Disorders

Molecular Defects in Chronic Myeloproliferative Disorders

... With the exception of chronic myeloid leu- kemia (CML), the molecular defects in chronic myeloproliferative disorders (MPDs) have not been elucidated. This poor molecular un- derstanding may contribute to ...

13

Co58B12 ABSORPTION, PLASMA TRANSPORT AND EXCRETION IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS, SOLID TUMORS AND NON NEOPLASTIC DISEASES

Co58B12 ABSORPTION, PLASMA TRANSPORT AND EXCRETION IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS, SOLID TUMORS AND NON NEOPLASTIC DISEASES

... Gastrointestinal absorption, plasma transport and urinary excretion of radioactivity following oral administration of 0.5 ,ug of Co5'8B2 have been evaluated in 24 patients, 7 of whom had[r] ...

9

DETECTION OF JAK-2 MUTATION BY PCR TECHNIQUE IN CHRONIC MYELOPROLIFERATIVE DISORDERS

DETECTION OF JAK-2 MUTATION BY PCR TECHNIQUE IN CHRONIC MYELOPROLIFERATIVE DISORDERS

... Despite this high expression of Jak2 mutation in PV and its relative lower expression in ET and MF it was found That Jak2 mutation expression was associated with increased risk of CMPNs including PV, ET and MF, and that ...

7

RETICULOENDOTHELIOSIS AND MYELOPROLIFERATIVE DISORDERS

RETICULOENDOTHELIOSIS AND MYELOPROLIFERATIVE DISORDERS

... gms., white cells 18,000, with an occasional early form and an occasional nucleated blood cell being seen on the smear, Two blood cul- tures were taken and were subsequently re-.. ported[r] ...

12

Granulopoiesis in Chronic Myeloproliferative Disorders in Children

Granulopoiesis in Chronic Myeloproliferative Disorders in Children

... §These compare with colony counts of 0 to 6 colonies (mean, 2.6) per 5 x 10 nucleated cells plated from the peripheral blood of ten normal children (ages, 4 to 16 years) studied in Dr.. [r] ...

7

Pulmonary hypertension in patients with chronic myeloproliferative disorders

Pulmonary hypertension in patients with chronic myeloproliferative disorders

... a myeloproliferative disorder may be the presence of a tumour microembolism, as found in various ...progressive myeloproliferative syndrome, translocation of megakaryocytes from the bone marrow, spleen or ...

11

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders

... While hematological malignancies represent less than 10 % of all cancer cases in the United States [1], studies into their pathogenesis have led to critical insights into the molecular mechanisms of cancer initiation and ...

6

Conditional expression of oncogenic K ras from its endogenous promoter induces a myeloproliferative disease

Conditional expression of oncogenic K ras from its endogenous promoter induces a myeloproliferative disease

... developed myeloproliferative disorders with long latency (107–385 days) and incomplete pene- trance, suggesting that secondary mutations were neces- sary for the phenotype ...

12

The Prevalence of JAK2-V617F Mutation in Sudanese Patients with Chronic Myeloproliferative Neoplasms

The Prevalence of JAK2 -V617F Mutation in Sudanese Patients with Chronic Myeloproliferative Neoplasms

... with myeloproliferative disorders referred to Isotope Center, and to investigate the differences of laboratory parameters between patients with JAK2-V617F positive myeloproliferative neoplasms (MPNs) ...

7

The Role of MicroRNAs in Myeloproliferative Neoplasia

The Role of MicroRNAs in Myeloproliferative Neoplasia

... suppressors. Myeloproliferative neoplasias (formerly known as chronic myeloproliferative disorders) form a class of hematologic malignancies demonstrating the expansion of stem cells in one or more ...

14

Psychiatric assessment of suicide attempters in Japan: a pilot study at a critical emergency unit in an urban area

Psychiatric assessment of suicide attempters in Japan: a pilot study at a critical emergency unit in an urban area

... Few reports have examined psychiatric diagnoses in cases of suicide attempts following the recent rise in the suicide rate in Japan [14-16]. Murase, et al. (2003) studied 100 attempted suicide cases, attempters and found ...

7

Myers’ Psychology for AP*

Myers’ Psychology for AP*

... Perspectives on Psychological Disorders Anxiety Disorders Somatoform Disorders Dissociative Disorders Mood Disorders Schizophrenia Personality Disorders Rates of Disorder.. Click on the [r] ...

130

Nandukkal, a fossil crab used in Siddha Medicine and its therapeutic usage – a review

Nandukkal, a fossil crab used in Siddha Medicine and its therapeutic usage – a review

... urinary disorders, mental disorders, Musculo skeletal disorders, dermatological disorders, gastro intestinal disorders, opthalmological disorders, veneral diseases, all kinds of ...

5

Non-suicidal self-injury (NSSI) and suicidal: Criteria differentiation

Non-suicidal self-injury (NSSI) and suicidal: Criteria differentiation

... significant disorders which are NSSI ...Mental Disorders, Fifth edition (DSM-5) by American Psychiatric Association – that has considered NSSI a separate class of ...

5

Show all 8303 documents...

Related subjects